[Factors associated with efficacy of cardiac resynchronization therapy for patients with congestive heart failure]

Hao-Ying Shi1, Wei Jin, Fang Wang

  • 1Department of Cardiology, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China.

Insights

Cardiac resynchronization therapy (CRT) is effective for heart failure, but less so for patients with atrial fibrillation. For sinus rhythm patients, QRS duration, LV pre-ejection time, and pulmonary systolic pressure predict CRT response.

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Cardiac Electrophysiology

Background:

  • Congestive heart failure (CHF) affects millions globally, with cardiac resynchronization therapy (CRT) offering a treatment option.
  • Identifying predictors of CRT response is crucial for optimizing patient selection and outcomes.

Purpose of the Study:

  • To evaluate the efficacy of CRT in patients with CHF.
  • To identify factors predicting responder versus non-responder status to CRT.

Main Methods:

  • Fifty-three CHF patients (sinus rhythm and atrial fibrillation) received CRT.
  • Echocardiography and tissue Doppler imaging assessed response 6 months post-implantation.
  • Clinical response: improved NYHA class; Echocardiographic response: reduced LV end-systolic volume or increased LVEF.

Main Results:

  • Overall clinical and echocardiographic response rates were 75% and 69.8%, respectively.
  • Atrial fibrillation patients showed significantly lower echocardiographic response rates (45.5%) compared to sinus rhythm patients (76.2%).
  • In sinus rhythm patients, wider QRS duration, lower pulmonary systolic pressure, and prolonged left ventricular pre-ejection time predicted better CRT response.

Conclusions:

  • CRT response is diminished in CHF patients with atrial fibrillation compared to those with sinus rhythm.
  • QRS duration, left ventricular pre-ejection time, and pulmonary systolic pressure are valuable predictors of CRT response in sinus rhythm patients.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...